Skip to main content

The Immune System

Under Control

Our Company

AbolerIS Pharma is a Belgian biopharmaceutical company developing a novel approach to the treatment of chronic autoimmune and inflammatory diseases.

Lead Program

AbolerIS Pharma is developing a first-in-class monoclonal antibody based on a novel scientific approach to restore the balance in the immune system.
Our novel and unique therapeutic approaches induce immune tolerance and preserve useful immune responses in inflammatory, autoimmune, and degenerative diseases.

Latest updates

AbolerIS Pharma is one of the laureates of the REACT-EU program 2022

| sticky | No Comments
Nantes, France, November 22, 2022 – AbolerIS Pharma is a pre-clinical stage biotech company specialized in the development of innovative immunomodulators for the treatment of transplant rejection, graft-versus-host-disease and auto-immune…

Joint Belgian-Dutch Immunology Meeting 2023

| Event | No Comments
21 & 22 November, 2023Antwerp, BelgiumThis two day event comprises presentations from several (international) key-note speakers, invited speakers and selected abstract presentations in plenary sessions as well as in break…

European Lifestars Awards

| Event | No Comments
13 November, 2023London, UKThe annual, European Lifestars Awards (ELAs) bring together hundreds of European life science leaders, investors, partners and deal makers. It is a celebration of the success stories,…